School of Medicine, University of Western Australia, Perth, Australia.
School of Medicine, University of Western Australia, Perth, Australia; Telethon Kids Institute, Perth, Australia.
J Steroid Biochem Mol Biol. 2020 Jul;201:105692. doi: 10.1016/j.jsbmb.2020.105692. Epub 2020 May 5.
Single nucleotide polymorphisms (SNPs) of the vitamin D receptor (VDR) gene have shown linkage and association with asthma development in multiple cohort studies. However, the majority of investigations have focused on asthma phenotypes in cohorts with stable disease. We investigated the relationship between VDR SNPs and the frequency and severity of acute episodes of wheeze/asthma in a cohort of Australian children, as the ability to identify children at risk of more severe exacerbations could lead to personalized and improved genotype-specific treatment pathways. We successfully genotyped five SNPs of the VDR gene (rs2525046, rs9729, rs1544410 (BsmI), rs22239179, and rs2228570 (FokI)) in 657 children presenting to a tertiary children's hospital with acute asthma, bronchiolitis, or a wheezing illness. The relationships between VDR SNPs and exacerbation severity scores, β-agonist use, and frequency of respiratory exacerbations were analysed using multiple regression. The rs2525046 (FokI) CT genotype was associated with higher VDR mRNA intensity levels (p = 0.007) compared to the CC genotype. A trend towards significance (p=0.056) was identified between the rs2525046 TT genotype and higher VDR mRNA intensity levels compared to the CC genotype. Children with rs2228570 AA genotype had higher exacerbation severity scores (p=0.001) and poorer β-agonist treatment response (doses at 6 h: p = 0.009 and 12 h: p=0.033) compared to those with the GG genotype. Children with rs1544410 (BsmI) TT genotype had lower exacerbation severity scores (p = 0.005) compared to those with the CC genotype. Children with rs2228570 GA genotype presented to and/or were admitted to hospital more times since birth with respiratory (p = 0.011) and wheezing (p = 0.021) illnesses than children with the GG genotype. No associations were identified between rs9729, rs2525046 and r2239179 polymorphisms and acute wheezing/asthma variables. These findings suggest that genetic variants at the VDR locus may play a role in acute wheeze/asthma severity in children.
单核苷酸多态性(SNP)的维生素 D 受体(VDR)基因已显示出与哮喘发展的连锁和关联在多个队列研究中。然而,大多数研究都集中在具有稳定疾病的队列中的哮喘表型上。我们调查了 VDR SNPs 与澳大利亚儿童队列中喘息/哮喘急性发作频率和严重程度之间的关系,因为能够识别更严重恶化风险的儿童可能会导致个性化和改善的基因型特异性治疗途径。我们成功地对 657 名因急性哮喘、细支气管炎或喘息性疾病就诊于三级儿童医院的儿童的 VDR 基因的五个 SNP(rs2525046、rs9729、rs1544410(BsmI)、rs22239179 和 rs2228570(FokI))进行了基因分型。使用多元回归分析 VDR SNPs 与加重严重程度评分、β-激动剂使用和呼吸加重频率之间的关系。与 CC 基因型相比,rs2525046(FokI)CT 基因型与更高的 VDR mRNA 强度水平相关(p=0.007)。与 CC 基因型相比,rs2525046 TT 基因型与更高的 VDR mRNA 强度水平之间存在显著趋势(p=0.056)。与 GG 基因型相比,rs2228570 AA 基因型的儿童加重严重程度评分更高(p=0.001),β-激动剂治疗反应更差(6 h 时剂量:p=0.009,12 h 时剂量:p=0.033)。与 CC 基因型相比,rs1544410(BsmI)TT 基因型的儿童加重严重程度评分较低(p=0.005)。与 GG 基因型相比,rs2228570 GA 基因型的儿童因呼吸道(p=0.011)和喘息(p=0.021)疾病就诊和/或住院次数更多。rs9729、rs2525046 和 r2239179 多态性与急性喘息/哮喘变量之间没有关联。这些发现表明 VDR 基因座的遗传变异可能在儿童急性喘息/哮喘严重程度中起作用。